KM Research Hub
← 返回论文库
已完成 入排:排除 图源:可得 入排置信度 0.98

Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial.

Yasser Jamil, Ajay Kirtane, Robert W Yeh, Richard Shlofmitz, Jeffrey Moses, William Bachinsky, Suhail Dohad, Steven Rudick, Robert Stoler, Brian K Jefferson, William Nicholson, John Altman, Amar Krishnaswamy, Khaldoon Alaswad, Carey Kimmelstiel, Arthur Reitman, Rafael Cavalcante, Behnam N Tehrani, Wayne B Batchelor

J Am Heart Assoc 15(2) e043053

PMID41553096
PMCIDPMC12919518
DOI10.1161/JAHA.125.043053
发表日期2026-01-19
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

BACKGROUND: Racial and ethnic minority patients have higher rates of adverse ischemic events following percutaneous coronary intervention. The impact of these disparities on the efficacy of drug-coated balloon (DCB) angioplasty for in-stent restenosis is unclear. We aimed to evaluate the comparative efficacy of DCB angioplasty among racial and ethnic minority patients presenting with in-stent restenosis. METHODS: This was a prespecified analysis of the AGENT IDE (A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA [Percutaneous Transluminal Coronary Angioplasty] Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis) trial which randomized patients with in-stent restenosis (2:1) to treatment with AGENT paclitaxel-coated balloon or conventional balloon angioplasty. The primary outcome was 1-year target lesion failure (composite of ischemia-driven target lesion revascularization, target vessel myocardial infarction, and cardiac death). Baseline clinical characteristics and outcomes were compared in minority patients versus non-Hispanic White patients and interaction terms used to determine if DCB efficacy was influenced by race or ethnicity. RESULTS: Of the 406 patients treated with DCB, 103 (25%) self-identified as minority patients (30.1% Black, 25.2% Hispanic/Latino, 8.7% Asian), and 303 (75%) as non-Hispanic White patients. Minority patients were younger (66 versus 69 years, P=0.003). There were no differences in 1-year target lesion failure (15.0% versus 18.9%; hazard ratio [HR], 0.79 [95% CI, 0.44-1.39]; P=0.41) or target lesion revascularization (11.1% versus 13.7%; HR, 0.80 [95% CI, 0.41-1.56]; P=0.51) between subgroups, including after adjustment for imbalances in baseline characteristics (adjusted odds ratio for target lesion failure 0.71 [95% CI, 0.37-1.34]). Both groups derived similar DCB benefit, with no significant treatment by race and ethnicity interaction (P-interaction >0.30 for all end points). CONCLUSIONS: In this prespecified analysis of the AGENT IDE trial, 1-year outcomes following DCB angioplasty were comparable between minority and non-Hispanic White patients. Although wide CIs limited the exclusion of clinically meaningful differences in outcomes between these groups, the relative efficacy of DCB versus balloon angioplasty was consistent across race and ethnicity. Registration: ClinicalTrials.gov; Identifier: NCT04647253. URL: https://www.clinicaltrials.gov/study/NCT04647253.

KM 提取结果

2 个 Figure · 2 个 KM 面板

进入结果中心
KM Figure1 个面板

Figure 1

Figure 1. Kaplan–Meier estimates of TLF through 1 year in minority patients and Non‐Hispanic White patients. The hazard ratio is calculated using the Cox proportional hazard regression model and the P value is calculated using the log‐rank test. DCB, indicates drug‐coated balloon; HR, hazard ratio; and TLF, target lesion failure.

Target_Lesion_Failure

TLF

Figure 1 · Panel Target_Lesion_Failure

quality_warning 待 EXE 对齐 预期 2 条 已提取 1 条

Panel Target_Lesion_Failure 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别疑似图例或人工水平线:轨迹出现不合理的共同平台曲线缺失:预期 2 条,实际恢复 1 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
KM Figure1 个面板

Figure 2

Figure 2. Kaplan–Meier estimates of TLR through 1 year in minority patients and Non‐Hispanic White patients. The hazard ratio is calculated using the Cox proportional hazard regression model and the P value is calculated using the log‐rank test. DCB indicates drug‐coated balloon; HR, hazard ratio; and TLR, target lesion revascularization.

Target_Lesion_Revascularization

TLR

Figure 2 · Panel Target_Lesion_Revascularization

quality_warning 待 EXE 对齐 预期 2 条 已提取 1 条

Panel Target_Lesion_Revascularization 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别疑似图例或人工水平线:轨迹出现不合理的共同平台曲线缺失:预期 2 条,实际恢复 1 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
其他 Figure(1,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 3Figure 3. Risk‐adjusted 1‐year outcomes in minority patients versus Non‐Hispanic White patients. The odds ratio and reported P values were obtained from the logistic regression model. DCB indicates drug‐coated balloon; TLF, target lesion failure; TLR, target lesion revascularization; and TV‐MI, target vessel myocardial infarction.
非 KM Figure